COVID-19 ICU Patients Found To Have Higher Burden Of Deliriu
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
COVID-19 patients admitted to intensive care in the early months of the pandemic were subject to a significantly higher burden of delirium and coma than is typically found in patients with acute respiratory failure.

The study, tracks the incidence of delirium and coma in 2,088 COVID-19 patients admitted to 69 adult intensive care units across 14 countries. 82% of patients in this observational study were comatose for a median of 10 days and 55% were delirious for a median of three days. Acute brain dysfunction lasted for a median of 12 days.

The authors find that, where COVID-19 is concerned, there has been an apparent widespread abandonment of newer clinical protocols that are proven to help ward off the acute brain dysfunction that stalks many critically ill patients. Using electronic health records, investigators were able to closely examine patient characteristics, care practices and findings from clinical assessments.

Acute brain dysfunction was highly prevalent and prolonged in critically ill patients with COVID-19. Benzodiazepine use and lack of family visitation were identified as modifiable risk factors for delirium, and thus these data present an opportunity to reduce acute brain dysfunction in patients with COVID-19.

Source:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30552-X/fulltext
Like
Comment
Share